Andreas Kungl
Research in focus July 2020
Intensive research is underway around the world to develop an active agent against SARS-CoV-2, the trigger of the Covid-19 disease. The University of Graz is now launching a fundraising campaign to advance an unconventional research approach. The goal is to prevent entry of the virus using a newly developed drug that will stop the pathogen from entering human cells via the surrounding matrix.
As part of the project, we stopped by Andreas Kungl's lab. In the video, the pharmacist explains what makes his approach to fighting Covid-19 so exciting.
Video: www.unreifundtaube.at